Jiang C, Zhao Z, East A, Bandyopadhyay S, Jiang Z, Chan J
Chem Sci. 2025; .
PMID: 39981039
PMC: 11837750.
DOI: 10.1039/d4sc08228a.
Zhang J, Hu Y, Wen X, Yang Z, Wang Z, Feng Z
Nat Nanotechnol. 2025; .
PMID: 39966684
DOI: 10.1038/s41565-025-01857-9.
Long F, Pu X, Wang X, Ma D, Gao S, Shi J
J Ovarian Res. 2025; 18(1):26.
PMID: 39940000
PMC: 11823222.
DOI: 10.1186/s13048-025-01590-w.
Tian Y, Sun M, Song R, Yang Z, Zhang H
RSC Adv. 2025; 15(4):2981-2987.
PMID: 39882009
PMC: 11775498.
DOI: 10.1039/d4ra07839j.
Yu H, Huang Z, Wu J, Zhao Z, Hua Y, Yang Y
Nanomedicine (Lond). 2025; 20(4):389-400.
PMID: 39877963
PMC: 11812356.
DOI: 10.1080/17435889.2025.2456450.
Facts, Dogmas, and Unknowns About Mitochondrial Reactive Oxygen Species in Cancer.
Junco M, Ventura C, Santiago Valtierra F, Maldonado E
Antioxidants (Basel). 2025; 13(12.
PMID: 39765891
PMC: 11673973.
DOI: 10.3390/antiox13121563.
Reactive Oxygen Species-Sensitive Nanophotosensitizers Composed of Buthionine Sulfoximine-Conjugated Chitosan Oligosaccharide for Enhanced Photodynamic Treatment of Cancer Cells.
Lee H, Park J, Kim T, Kim T, Kim D, Yun J
Int J Mol Sci. 2024; 25(23).
PMID: 39684320
PMC: 11641636.
DOI: 10.3390/ijms252312609.
Research progress of paclitaxel nanodrug delivery system in the treatment of triple-negative breast cancer.
Qiao J, Guo D, Tian H, Wang Z, Fan Q, Tian Y
Mater Today Bio. 2024; 29:101358.
PMID: 39677523
PMC: 11638641.
DOI: 10.1016/j.mtbio.2024.101358.
Organelle-Specific Smart Supramolecular Materials for Bioimaging and Theranostics Application.
Bharathidasan D, Maity C
Top Curr Chem (Cham). 2024; 383(1):1.
PMID: 39607460
DOI: 10.1007/s41061-024-00483-8.
Recent development of nanotechnology-based approaches for gynecologic cancer therapy.
Gedda G, Park Y, Pang M
Obstet Gynecol Sci. 2024; 68(1):18-29.
PMID: 39591955
PMC: 11788694.
DOI: 10.5468/ogs.24180.
Design Principles and Applications of Fluorescent Kinase Inhibitors for Simultaneous Cancer Bioimaging and Therapy.
Ganai A, Vrettos E, Kyrkou S, Zoi V, Khan Pathan T, Karpoormath R
Cancers (Basel). 2024; 16(21).
PMID: 39518106
PMC: 11545566.
DOI: 10.3390/cancers16213667.
Self-immolative polydisulfides and their use as nanoparticles for drug delivery systems.
Vollmecke K, Kramer M, Horky C, Duckmann O, Mulac D, Langer K
RSC Adv. 2024; 14(48):35568-35577.
PMID: 39512642
PMC: 11541933.
DOI: 10.1039/d4ra07228f.
Current views on mechanisms of the FLASH effect in cancer radiotherapy.
Ma Y, Zhang W, Zhao Z, Lv J, Chen J, Yan X
Natl Sci Rev. 2024; 11(10):nwae350.
PMID: 39479528
PMC: 11523052.
DOI: 10.1093/nsr/nwae350.
Strain-dependent glutathionylation of fibronectin fibers impacts mechano-chemical behavior and primes an integrin switch.
Li W, Moretti L, Su X, Yeh C, Torres M, Barker T
Nat Commun. 2024; 15(1):8751.
PMID: 39384749
PMC: 11479631.
DOI: 10.1038/s41467-024-52742-3.
Glutathione-Dependent Pathways in Cancer Cells.
Kalinina E
Int J Mol Sci. 2024; 25(15).
PMID: 39125992
PMC: 11312684.
DOI: 10.3390/ijms25158423.
Biosensors for Cancer Biomarkers Based on Mesoporous Silica Nanoparticles.
Mladenovic M, Jaric S, Mundzic M, Pavlovic A, Bobrinetskiy I, Knezevic N
Biosensors (Basel). 2024; 14(7).
PMID: 39056602
PMC: 11274377.
DOI: 10.3390/bios14070326.
Unveiling the impact of glutathione (GSH) and gene deletion on tumor cell metabolism by amino acid and proteomics analysis.
Zhang H, Zhou J, Dong L, Zhu L, Ye Y
J Gastrointest Oncol. 2024; 15(3):1002-1019.
PMID: 38989407
PMC: 11231838.
DOI: 10.21037/jgo-24-236.
Glutathione and Xanthine Metabolic Changes in Tamoxifen Resistant Breast Cancer Cell Lines are Mediated by Down-Regulation of and and Correlated to Poor Prognosis.
Alwahsh M, Hamadneh Y, Marchan R, Dahabiyeh L, Alhusban A, Hasan A
J Cancer. 2024; 15(13):4047-4058.
PMID: 38947399
PMC: 11212086.
DOI: 10.7150/jca.96659.
Photosynthetic bacteria-based whole-cell inorganic-biohybrid system for multimodal enhanced tumor radiotherapy.
Hua S, Zhao J, Li L, Liu C, Zhou L, Li K
J Nanobiotechnology. 2024; 22(1):379.
PMID: 38943158
PMC: 11212166.
DOI: 10.1186/s12951-024-02654-7.
Fc-Fc interactions and immune inhibitory effects of IgG4: implications for anti-PD-1 immunotherapies.
Zhang W, Chen X, Chen X, Li J, Wang H, Yan X
J Immunother Cancer. 2024; 12(6).
PMID: 38925680
PMC: 11203076.
DOI: 10.1136/jitc-2024-009034.